this is like one of those therapies in BUT IM A CHEERLEADER
January 22, 2026 at 6:39 PM
this is like one of those therapies in BUT IM A CHEERLEADER
Acceso a bibliografía en @PubMedOnline
Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits
Chi Kin Wong et al. J Clin Invest. 2025.
pubmed.ncbi.nlm.nih.gov/41178710/
Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits
Chi Kin Wong et al. J Clin Invest. 2025.
pubmed.ncbi.nlm.nih.gov/41178710/
January 22, 2026 at 6:26 PM
Acceso a bibliografía en @PubMedOnline
Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits
Chi Kin Wong et al. J Clin Invest. 2025.
pubmed.ncbi.nlm.nih.gov/41178710/
Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits
Chi Kin Wong et al. J Clin Invest. 2025.
pubmed.ncbi.nlm.nih.gov/41178710/
Facial wounds heal with less scarring than those on the body due to unique fibroblast pathways, suggesting potential for scar-reducing therapies after surgery or trauma.
The face scars less than the body: Study explains why
Tweaking a pattern of wound healing established millions of years ago may enable scar-free injury repair after surgery or trauma, Stanford Medicine researchers have found.
medicalxpress.com
January 22, 2026 at 6:23 PM
Facial wounds heal with less scarring than those on the body due to unique fibroblast pathways, suggesting potential for scar-reducing therapies after surgery or trauma.
Representatives from #AASLD, including AASLD Past President Grace L. Su, MD, FAASLD, speak with Congressman John Moolenaar to share how #GLP1 therapies are redefining the standard of care for #obesity and #liverdisease.
January 22, 2026 at 6:06 PM
Representatives from #AASLD, including AASLD Past President Grace L. Su, MD, FAASLD, speak with Congressman John Moolenaar to share how #GLP1 therapies are redefining the standard of care for #obesity and #liverdisease.
6 New Weight Loss Drugs That Could Dethrone Ozempic: Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight. https://ranked.news/141873?u=b
January 22, 2026 at 6:04 PM
6 New Weight Loss Drugs That Could Dethrone Ozempic: Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight. https://ranked.news/141873?u=b
Advances in therapies for schistosomiasis, also known to cause "snail fever" and liver fibrosis, can lead to protection of patients and populations in areas with increased exposure. Identification of Mzb1 can lead to further studies to aid patients, especially for pediatric infections. #Pitt_ID26
Mzb1 Promotes Progression of Schistosomiasis by Inducing Endoplasmic Reticulum Stress
✅ Just Accepted
🔗 https://bit.ly/4pRhXzM
✅ Just Accepted
🔗 https://bit.ly/4pRhXzM
January 22, 2026 at 5:59 PM
Advances in therapies for schistosomiasis, also known to cause "snail fever" and liver fibrosis, can lead to protection of patients and populations in areas with increased exposure. Identification of Mzb1 can lead to further studies to aid patients, especially for pediatric infections. #Pitt_ID26
UNSW Sydney: '$4.7 million for UNSW researchers to investigate long COVID'
'The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.'
www.unsw.edu.au/newsroom/new...
'The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.'
www.unsw.edu.au/newsroom/new...
$4.7 million for UNSW researchers to investigate long COVID
The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.
www.unsw.edu.au
January 22, 2026 at 5:30 PM
UNSW Sydney: '$4.7 million for UNSW researchers to investigate long COVID'
'The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.'
www.unsw.edu.au/newsroom/new...
'The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.'
www.unsw.edu.au/newsroom/new...
Antibiotic resistance is spreading – but the good news is that scientists are developing faster diagnostics, gene-editing tools and alternative therapies to fight back. 🩺🧪 buff.ly/3o1579B
Antibiotic resistance could undo a century of medical progress – but four advances are changing the story
Antibiotics transformed health care for the better, but their diminishing effectiveness may soon be its undoing. Researchers are studying ways to fight back against resistance.
buff.ly
January 22, 2026 at 5:14 PM
Antibiotic resistance is spreading – but the good news is that scientists are developing faster diagnostics, gene-editing tools and alternative therapies to fight back. 🩺🧪 buff.ly/3o1579B
From the discovery of insulin 100 years ago to today’s potential cures in clinical trials, every breakthrough has been driven by university research. The future depends on continued investment in merit-based science. bit.ly/3LSwAES
January 22, 2026 at 4:58 PM
From the discovery of insulin 100 years ago to today’s potential cures in clinical trials, every breakthrough has been driven by university research. The future depends on continued investment in merit-based science. bit.ly/3LSwAES
• Se faire accompagner par un psychomotricien, qui est spécialisé dans les thérapies d'habituation.
• Laisser les gens s'isoler temporairement pendant les rassemblements sociaux sans mettre de pression en jugeant
• Baissez le son.
• NE PIAFFEZ PAS.
Voila voila. J'ai pas de conclusion.
20/20
• Laisser les gens s'isoler temporairement pendant les rassemblements sociaux sans mettre de pression en jugeant
• Baissez le son.
• NE PIAFFEZ PAS.
Voila voila. J'ai pas de conclusion.
20/20
January 22, 2026 at 4:51 PM
• Se faire accompagner par un psychomotricien, qui est spécialisé dans les thérapies d'habituation.
• Laisser les gens s'isoler temporairement pendant les rassemblements sociaux sans mettre de pression en jugeant
• Baissez le son.
• NE PIAFFEZ PAS.
Voila voila. J'ai pas de conclusion.
20/20
• Laisser les gens s'isoler temporairement pendant les rassemblements sociaux sans mettre de pression en jugeant
• Baissez le son.
• NE PIAFFEZ PAS.
Voila voila. J'ai pas de conclusion.
20/20
🚀 Big news in biomedical innovation! Vanderbilt University has launched the Vanderbilt Institute for Therapeutic Advances, a new research powerhouse designed to redefine how discoveries become real therapies. 👉 news.vanderbilt.edu/2026/01/21/v...
Vanderbilt Institute for Therapeutic Advances launches to redefine drug discovery and biomedical innovation
New drug discovery institute brings together AI, genomics, systems biology and translational research to accelerate cures for major diseases.
news.vanderbilt.edu
January 22, 2026 at 4:45 PM
🚀 Big news in biomedical innovation! Vanderbilt University has launched the Vanderbilt Institute for Therapeutic Advances, a new research powerhouse designed to redefine how discoveries become real therapies. 👉 news.vanderbilt.edu/2026/01/21/v...
This review shows how disrupted #MitochondrialQualityControl—covering #biogenesis, dynamics, #Mitophagy, #Proteostasis, and stress responses—fuels oxidative injury, #inflammation, and lipid buildup in #Atherosclerosis, while MQC‑targeted therapies hold promise.
#OpenAccess: tinyurl.com/23jddr2m
#OpenAccess: tinyurl.com/23jddr2m
Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis
Explore how mitochondrial quality control impacts atherosclerosis development and discover emerging therapies targeting MQC pathways to restore vascular health
tinyurl.com
January 22, 2026 at 4:44 PM
This review shows how disrupted #MitochondrialQualityControl—covering #biogenesis, dynamics, #Mitophagy, #Proteostasis, and stress responses—fuels oxidative injury, #inflammation, and lipid buildup in #Atherosclerosis, while MQC‑targeted therapies hold promise.
#OpenAccess: tinyurl.com/23jddr2m
#OpenAccess: tinyurl.com/23jddr2m
Gene therapies are revolutionising medicine, but they come with enormous development costs.
Why Do Gene Therapies Cost So Much?🤔
Read more in our blog⬇️:
https://www.fiosgenomics.com/why-do-gene-therapies-cost-so-much/
Why Do Gene Therapies Cost So Much?🤔
Read more in our blog⬇️:
https://www.fiosgenomics.com/why-do-gene-therapies-cost-so-much/
January 22, 2026 at 4:30 PM
Gene therapies are revolutionising medicine, but they come with enormous development costs.
Why Do Gene Therapies Cost So Much?🤔
Read more in our blog⬇️:
https://www.fiosgenomics.com/why-do-gene-therapies-cost-so-much/
Why Do Gene Therapies Cost So Much?🤔
Read more in our blog⬇️:
https://www.fiosgenomics.com/why-do-gene-therapies-cost-so-much/
6/ Breakthrough therapies are a huge part of the story. Immunotherapies, targeted drugs, and improved treatments have driven dramatic gains for cancers like lung cancer and multiple myeloma.
👉 statnews.com/2026/01/13/why-more-people-survive-cancer-new-report/
👉 statnews.com/2026/01/13/why-more-people-survive-cancer-new-report/
More people are surviving cancer than ever before, according to new report
More people are surviving cancer than ever before, as the 5-year survival rate across cancer reached 70%, according to the American Cancer Society’s new report.
statnews.com
January 22, 2026 at 4:13 PM
6/ Breakthrough therapies are a huge part of the story. Immunotherapies, targeted drugs, and improved treatments have driven dramatic gains for cancers like lung cancer and multiple myeloma.
👉 statnews.com/2026/01/13/why-more-people-survive-cancer-new-report/
👉 statnews.com/2026/01/13/why-more-people-survive-cancer-new-report/
I love having a crash out only for NHS talking therapies to get in touch midway through to remind me that I've now been on a waiting list for nine months.
January 22, 2026 at 3:56 PM
I love having a crash out only for NHS talking therapies to get in touch midway through to remind me that I've now been on a waiting list for nine months.
Notre PDG, Cate Murray, explique comment le RCS traduit sa mission en actes, à savoir par des investissements stratégiques, des paris audacieux sur l’innovation canadienne et un engagement à faire passer les thérapies du laboratoire au chevet des patients. #AnniversaireDArgentRCS
(1/8) Nous célébrons notre 25e anniversaire et sommes ravis de ce que nous avons accompli et de ce que l’avenir nous réserve.
Dans cette vidéo, je médite sur l’année 2025 et sur nos efforts pour soutenir la recherche et les #EssaisCliniques, lançant un tout nouveau programme…
Dans cette vidéo, je médite sur l’année 2025 et sur nos efforts pour soutenir la recherche et les #EssaisCliniques, lançant un tout nouveau programme…
Transforming Lives Through Regenerative Medicine | The Stem Cell Network
YouTube video by Stem Cell Network - Réseau de cellules souches
www.youtube.com
January 22, 2026 at 3:54 PM
Notre PDG, Cate Murray, explique comment le RCS traduit sa mission en actes, à savoir par des investissements stratégiques, des paris audacieux sur l’innovation canadienne et un engagement à faire passer les thérapies du laboratoire au chevet des patients. #AnniversaireDArgentRCS
Our President & CEO, Cate Murray, shares how SCN is putting its mission into action—through strategic investment, bold bets on Canadian innovation, and a commitment to moving therapies from lab to clinic. #SCNSilverAnniversary
(1/5) It’s our 25th anniversary, and we’re excited about what we’ve achieved and where we’re going.
In this video, I reflect on 2025 and our focus on supporting research and #ClinicalTrials, launching a brand-new investment program for #CDNbiotechs, and leading policy conversations
In this video, I reflect on 2025 and our focus on supporting research and #ClinicalTrials, launching a brand-new investment program for #CDNbiotechs, and leading policy conversations
Transforming Lives Through Regenerative Medicine | The Stem Cell Network
YouTube video by Stem Cell Network - Réseau de cellules souches
www.youtube.com
January 22, 2026 at 3:53 PM
Our President & CEO, Cate Murray, shares how SCN is putting its mission into action—through strategic investment, bold bets on Canadian innovation, and a commitment to moving therapies from lab to clinic. #SCNSilverAnniversary
2025 ATA Guidelines: Differentiated Thyroid Cancer
🧪 Revised regimen covers cancer diagnosis to subsequent therapies
📊 Data-driven decisions prioritize patient journey in DTC
#ThyroidCancer #DTC #ATAGuidelines #Pub2Post
https://tnyp.me/klrDiXX5/s
🧪 Revised regimen covers cancer diagnosis to subsequent therapies
📊 Data-driven decisions prioritize patient journey in DTC
#ThyroidCancer #DTC #ATAGuidelines #Pub2Post
https://tnyp.me/klrDiXX5/s
January 22, 2026 at 3:48 PM
2025 ATA Guidelines: Differentiated Thyroid Cancer
🧪 Revised regimen covers cancer diagnosis to subsequent therapies
📊 Data-driven decisions prioritize patient journey in DTC
#ThyroidCancer #DTC #ATAGuidelines #Pub2Post
https://tnyp.me/klrDiXX5/s
🧪 Revised regimen covers cancer diagnosis to subsequent therapies
📊 Data-driven decisions prioritize patient journey in DTC
#ThyroidCancer #DTC #ATAGuidelines #Pub2Post
https://tnyp.me/klrDiXX5/s
Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, according to an analysis of real-world data shared with Reuters that sheds light on a chief concern about the therapies.
Many patients may keep off lost pounds after stopping a GLP-1, U.S. data suggests
Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, according to an analysis of real-world data shared with Reuters that sheds light on a chief concern about the therapies.
bit.ly
January 22, 2026 at 3:40 PM
Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, according to an analysis of real-world data shared with Reuters that sheds light on a chief concern about the therapies.
📢 Funding opportunity
VSS has opened an Expression of Interest for organisations to deliver psychological & talking therapies (incl. family therapy) for under-18s affected by the Troubles/conflict.
Part of the Victims Support Programme 2026–28.
⏰ Closes 30 Jan 2026, 12 noon
🔗 tinyurl.com/526kxkd4
VSS has opened an Expression of Interest for organisations to deliver psychological & talking therapies (incl. family therapy) for under-18s affected by the Troubles/conflict.
Part of the Victims Support Programme 2026–28.
⏰ Closes 30 Jan 2026, 12 noon
🔗 tinyurl.com/526kxkd4
Victims Support Programme 2026-28 Expression of Interest Process - Victims and Survivors Service
tinyurl.com
January 22, 2026 at 3:34 PM
📢 Funding opportunity
VSS has opened an Expression of Interest for organisations to deliver psychological & talking therapies (incl. family therapy) for under-18s affected by the Troubles/conflict.
Part of the Victims Support Programme 2026–28.
⏰ Closes 30 Jan 2026, 12 noon
🔗 tinyurl.com/526kxkd4
VSS has opened an Expression of Interest for organisations to deliver psychological & talking therapies (incl. family therapy) for under-18s affected by the Troubles/conflict.
Part of the Victims Support Programme 2026–28.
⏰ Closes 30 Jan 2026, 12 noon
🔗 tinyurl.com/526kxkd4
Regenerative medicine at its peak now available in Abuja.
As regenerative care continues to evolve globally, we bring advanced, non-invasive therapies designed to support the body’s natural healing process. Trusted by patients, guided by medical expertise #trump #abuja #regenerativemedicine #viral
As regenerative care continues to evolve globally, we bring advanced, non-invasive therapies designed to support the body’s natural healing process. Trusted by patients, guided by medical expertise #trump #abuja #regenerativemedicine #viral
January 22, 2026 at 3:26 PM
Regenerative medicine at its peak now available in Abuja.
As regenerative care continues to evolve globally, we bring advanced, non-invasive therapies designed to support the body’s natural healing process. Trusted by patients, guided by medical expertise #trump #abuja #regenerativemedicine #viral
As regenerative care continues to evolve globally, we bring advanced, non-invasive therapies designed to support the body’s natural healing process. Trusted by patients, guided by medical expertise #trump #abuja #regenerativemedicine #viral
(6/8) La #MédecineRégénératrice est très polyvalente.
Elle permet de lutter contre les maladies rares à l’aide de thérapies géniques, de déployer des traitements cellulaires pour réparer les tissus et les organes endommagés…
Elle permet de lutter contre les maladies rares à l’aide de thérapies géniques, de déployer des traitements cellulaires pour réparer les tissus et les organes endommagés…
January 22, 2026 at 3:23 PM
(6/8) La #MédecineRégénératrice est très polyvalente.
Elle permet de lutter contre les maladies rares à l’aide de thérapies géniques, de déployer des traitements cellulaires pour réparer les tissus et les organes endommagés…
Elle permet de lutter contre les maladies rares à l’aide de thérapies géniques, de déployer des traitements cellulaires pour réparer les tissus et les organes endommagés…
(5/8) Nous devrons axer pleinement nos efforts sur la modernisation de nos structures réglementaires, d’évaluation de la santé et de remboursement, tout en préparant nos systèmes de santé à adopter et à fournir les thérapies révolutionnaires et vitales qui s’en viennent.
January 22, 2026 at 3:23 PM
(5/8) Nous devrons axer pleinement nos efforts sur la modernisation de nos structures réglementaires, d’évaluation de la santé et de remboursement, tout en préparant nos systèmes de santé à adopter et à fournir les thérapies révolutionnaires et vitales qui s’en viennent.
(2/8) … d’investissement dans les #EntreprisesBiotechnologiquesCanadiennes ainsi que des conversations politiques sur l’état de préparation du système de santé et l’adoption des thérapies de #MédecineRégénératrice.
January 22, 2026 at 3:23 PM
(2/8) … d’investissement dans les #EntreprisesBiotechnologiquesCanadiennes ainsi que des conversations politiques sur l’état de préparation du système de santé et l’adoption des thérapies de #MédecineRégénératrice.
(4/5) that are coming.
#RegenMed is cross-cutting. It is about fighting rare diseases with gene therapies, deploying cellular treatments to repair damaged tissues and organs, and restoring health and well-being for those living with chronic diseases
#RegenMed is cross-cutting. It is about fighting rare diseases with gene therapies, deploying cellular treatments to repair damaged tissues and organs, and restoring health and well-being for those living with chronic diseases
January 22, 2026 at 3:23 PM
(4/5) that are coming.
#RegenMed is cross-cutting. It is about fighting rare diseases with gene therapies, deploying cellular treatments to repair damaged tissues and organs, and restoring health and well-being for those living with chronic diseases
#RegenMed is cross-cutting. It is about fighting rare diseases with gene therapies, deploying cellular treatments to repair damaged tissues and organs, and restoring health and well-being for those living with chronic diseases